SCHEMBL2925571

SCHEMBL2925571

COC(=O)[C@H](Cc1ccc(OCCc2nc(-c3ccccc3)oc2C)cc1)NC(=O)OC(C)(C)C

nearest known ligand 0.68

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
PPARG P37231 20/20 0.68
PPARA Q07869 14/20 0.66
PPARD Q03181 7/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7914288 1.00 PPARG (0.68) PPARGPPARAPPARD
SCHEMBL6203537 0.90 PPARG (0.67) PPARGPPARAPPARD
SCHEMBL4026006 0.88 PPARG (0.65) PPARGPPARAPPARD
SCHEMBL7897370 0.88 PPARG (0.67) PPARGPPARAPPARD
SCHEMBL7903513 0.86 PPARG (0.68) PPARGPPARAPPARD
SCHEMBL4026004 0.85 PPARG (0.61) PPARGPPARAPPARD
SCHEMBL7897417 0.85 PPARG (0.70) PPARGPPARAPPARD
SCHEMBL7904793 0.84 PPARG (0.75) PPARGPPARAPPARD
SCHEMBL2926077 0.84 PPARG (0.70) PPARGPPARAPPARD
SCHEMBL2926075 0.84 PPARG (0.70) PPARGPPARAPPARD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1757596-B1 TYROSINE DERIVATIVES SUBSTITUTED BY N-PHENYLACRYLOYL AS AGONISTS OF HPPAR ALPHA AND HPPAR GAMA BEIJING MOLECULE SCIENCE AND T (CN) 2010-09-29 EP disclosed
US-7781468-B2 Tyrosine derivatives substituted by N-arylacryloyl as agonists of hPPAR alpha and/or hPPAR gamma Beijing Molecule Science Technology Co., Ltd. (CN) 2010-08-24 US disclosed
US-7544687-B2 Substituted α-piperazinyl phenylpropionic acid derivatives as hPPAR α and/or hPPAR γ agonists BEIJING MOLECULE SCIENCE AND TECHNOLOGY CO., LTD (CN) 2009-06-09 US disclosed
US-20080300286-A1 Tyrosine Derivatives Substituted By N-Arylacryloyl as Agonists of Hppar Alpha and/or Hppar Gamma BEIJING MOLECULE SCIENCE AND TECHNOLOGY CO., LTD (CN) 2008-12-04 US disclosed
US-20070259883-A1 Substitued A-Piperazingly Phenylpropionic Acid Derivatives As Hppar Alpha And/Or Hppar Gamma Agonists BEIJING MOLECULE SCIENCE AND TECHNOLOGY CO., LTD. (CN) 2007-11-08 US disclosed
EP-1757596-A1 TYROSINE DERIVATIVES SUBSTITUTED BY N-PHENYLACRYLOYL AS AGONISTS OF HPPAR ALPHA AND HPPAR GAMA Beijing Molecule Science and Technology Co., Ltd. (CN) 2007-02-28 EP disclosed
EP-0888317-B1 SUBSTITUTED 4-HYDROXY-PHENYLALCANOIC ACID DERIVATIVES WITH AGONIST ACTIVITY TO PPAR-GAMMA GLAXO GROUP LTD (GB) 2001-09-12 EP disclosed
EP-0888317-A1 SUBSTITUTED 4-HYDROXY-PHENYLALCANOIC ACID DERIVATIVES WITH AGONIST ACTIVITY TO PPAR-GAMMA GLAXO GROUP LIMITED (GB) 1999-01-07 EP disclosed
WO-1997031907-A1 SUBSTITUTED 4-HYDROXY-PHENYLALCANOIC ACID DERIVATIVES WITH AGONIST ACTIVITY TO PPAR-GAMMA GLAXO GROUP LIMITED (GB) 1997-09-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070259883-A1 Substitued A-Piperazingly Phenylpropionic Acid Derivatives As Hppar Alpha And/Or Hppar Gamma Agonists GPR119, PPARG, PPARA PPARG 2/4885PPARA 3/4885PPARD 11/4885
US-20080300286-A1 Tyrosine Derivatives Substituted By N-Arylacryloyl as Agonists of Hppar Alpha and/or Hppar Gamma GPR119, MTTP, GLP1R PPARG 215/4885PPARA 216/4885PPARD 330/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.